News | November 10, 2023
Intermountain Health files complain against Dr. Reddy’s and others
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
All claims against the company in the litigation have now been dismissed.
The settlement and dismissal resolves all claims between the parties
An estimated 21 million American women experience BV
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Subscribe To Our Newsletter & Stay Updated
